The crystal structure of N-acetyl-alpha-D-glucosamine.

PubWeight™: 1.20‹?› | Rank: Top 10%

🔗 View Article (PMID 6013453)

Published in Acta Crystallogr on December 10, 1966

Authors

L N Johnson

Articles by these authors

(truncated to the top 100)

Crystallographic studies of the activity of hen egg-white lysozyme. Proc R Soc Lond B Biol Sci (1967) 4.25

The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases. Nat Cell Biol (1999) 3.83

The structure of ribonuclease-S at 3.5 A resolution. J Biol Chem (1967) 2.33

The crystal structure of cyclin A. Structure (1995) 2.28

Structural changes in glycogen phosphorylase induced by phosphorylation. Nature (1988) 2.16

The allosteric transition of glycogen phosphorylase. Nature (1989) 1.84

Isolated inferior oblique paresis from brain-stem infarction. Perspective on oculomotor fascicular organization in the ventral midbrain tegmentum. Arch Neurol (1990) 1.80

Structural mechanism for glycogen phosphorylase control by phosphorylation and AMP. J Mol Biol (1991) 1.70

The crystal structure of a phosphorylase kinase peptide substrate complex: kinase substrate recognition. EMBO J (1997) 1.68

Structure of some crystalline lysozyme-inhibitor complexes determined by X-ray analysis at 6 Angstrom resolution. Nature (1965) 1.68

Catalysis in the crystal: synchrotron radiation studies with glycogen phosphorylase b. EMBO J (1987) 1.60

Phosphoprotein-protein interactions revealed by the crystal structure of kinase-associated phosphatase in complex with phosphoCDK2. Mol Cell (2001) 1.59

Effects of phosphorylation of threonine 160 on cyclin-dependent kinase 2 structure and activity. J Biol Chem (1999) 1.56

Design of a diffractometer and flow cell system for X-ray analysis of crystalline proteins with applications to the crystal chemistry of ribonuclease-S. J Mol Biol (1967) 1.56

Sphenoid sinus mucocele (anterior clinoid variant) mimicking diabetic ophthalmoplegia and retrobulbar neuritis. Am J Ophthalmol (1986) 1.51

Optic nerve compression by a dolichoectatic internal carotid artery: case report. Neurosurgery (1996) 1.46

Crystal structure of a lysozyme-tetrasaccharide lactone complex. J Mol Biol (1974) 1.43

Two structures of the catalytic domain of phosphorylase kinase: an active protein kinase complexed with substrate analogue and product. Structure (1995) 1.41

Sinus tumors invading the orbit. Ophthalmology (1984) 1.38

The cyclin box fold: protein recognition in cell-cycle and transcription control. Trends Biochem Sci (1997) 1.34

The crystal structure of triacylglycerol lipase from Pseudomonas glumae reveals a partially redundant catalytic aspartate. FEBS Lett (1993) 1.32

Protein-oligosaccharide interactions: lysozyme, phosphorylase, amylases. Curr Top Microbiol Immunol (1988) 1.30

The structure of ribonuclease-S at 6 A resolution. J Biol Chem (1967) 1.18

Subunit structure of aldolase: chemical and crystallographic evidence. J Mol Biol (1969) 1.17

Comparison of the binding of glucose and glucose 1-phosphate derivatives to T-state glycogen phosphorylase b. Biochemistry (1990) 1.16

Protein kinase inhibition by staurosporine revealed in details of the molecular interaction with CDK2. Nat Struct Biol (1997) 1.16

The crystal structure of Escherichia coli maltodextrin phosphorylase provides an explanation for the activity without control in this basic archetype of a phosphorylase. EMBO J (1997) 1.14

Identification of novel purine and pyrimidine cyclin-dependent kinase inhibitors with distinct molecular interactions and tumor cell growth inhibition profiles. J Med Chem (2000) 1.13

A new allosteric site in glycogen phosphorylase b as a target for drug interactions. Structure (2000) 1.12

Crystallographic studies on the activity of glycogen phosphorylase b. Nature (1978) 1.12

Crystal structure of the cell cycle-regulatory protein suc1 reveals a beta-hinge conformational switch. Proc Natl Acad Sci U S A (1995) 1.10

The crystal structure of p13suc1, a p34cdc2-interacting cell cycle control protein. EMBO J (1995) 1.08

Phosphorylase recognition and phosphorolysis of its oligosaccharide substrate: answers to a long outstanding question. EMBO J (1999) 1.07

Monocular elevation paresis and incomplete ptosis due to midbrain infarction involving the fascicular segment of the oculomotor nerve. J Clin Neuroophthalmol (1992) 1.04

Oligosaccharide substrate binding in Escherichia coli maltodextrin phosphorylase. Nat Struct Biol (1997) 1.04

Substrate-cofactor interactions for glycogen phosphorylase b: a binding study in the crystal with heptenitol and heptulose 2-phosphate. Biochemistry (1984) 1.04

Changes in absorption spectrum and crystal structure of triose phosphate isomerase brought about by 2-phosphoglycollate, a potential transition state analogue. J Mol Biol (1970) 1.04

Design of inhibitors of glycogen phosphorylase: a study of alpha- and beta-C-glucosides and 1-thio-beta-D-glucose compounds. Biochemistry (1994) 1.02

Enzymatic catalysis in crystals of Escherichia coli maltodextrin phosphorylase. J Mol Biol (2002) 1.02

Millisecond X-ray diffraction and the first electron density map from Laue photographs of a protein crystal. Nature (1987) 1.01

The crystal structure of phosphorylase beta at 6 A resolution. J Mol Biol (1974) 1.00

Structural studies on phospho-CDK2/cyclin A bound to nitrate, a transition state analogue: implications for the protein kinase mechanism. Biochemistry (2002) 0.99

The binding of monosaccharide inhibitors to hen egg-white lysozyme by proton magnetic resonance at 270 MHz and analysis by ring-current calculations. Biochem J (1981) 0.98

Uridine(5')diphospho(1)-alpha-D-glucose. A binding study to glycogen phosphorylase b in the crystal. Eur J Biochem (1988) 0.98

Glucose analogue inhibitors of glycogen phosphorylase: the design of potential drugs for diabetes. Biochemistry (1991) 0.97

The structure of glycogen phosphorylase b with an alkyldihydropyridine-dicarboxylic acid compound, a novel and potent inhibitor. Structure (1997) 0.97

Papilledema: clinical clues and differential diagnosis. Am Fam Physician (1992) 0.96

Follistatin: essential role for the N-terminal domain in activin binding and neutralization. J Biol Chem (2001) 0.96

Progress with Laue diffraction studies on protein and virus crystals. Biochemistry (1990) 0.95

Crystal structures of egg-white lysozyme of hen in acetate-free medium and of lysozyme complexes with N-acetylglucosamine and beta-methyl N-acetylglucosaminide. Biochem J (1978) 0.95

The molecular mechanism for the tetrameric association of glycogen phosphorylase promoted by protein phosphorylation. Protein Sci (1992) 0.95

Catalytic mechanism of phosphorylase kinase probed by mutational studies. Biochemistry (1999) 0.95

Channels at the catalytic site of glycogen phosphorylase b: binding and kinetic studies with the beta-glycosidase inhibitor D-gluconohydroximo-1,5-lactone N-phenylurethane. Biochemistry (1988) 0.94

The activity of lysozyme: an interim review of crystallographic and chemical evidence. Brookhaven Symp Biol (1968) 0.93

Crystallization of pig skeletal phosphorylase b. Purification, physical and catalytic characterization. Biochim Biophys Acta (1985) 0.93

The structure of a glycogen phosphorylase glucopyranose spirohydantoin complex at 1.8 A resolution and 100 K: the role of the water structure and its contribution to binding. Protein Sci (1998) 0.93

Ternary complex crystal structures of glycogen phosphorylase with the transition state analogue nojirimycin tetrazole and phosphate in the T and R states. Biochemistry (1996) 0.93

Effects of C-1-substituted glucose analogue on the activation states of glycogen synthase and glycogen phosphorylase in rat hepatocytes. Biochem J (1995) 0.92

Phosphorylase: control and activity. Philos Trans R Soc Lond B Biol Sci (1981) 0.91

N-acetyl-beta-D-glucopyranosylamine: a potent T-state inhibitor of glycogen phosphorylase. A comparison with alpha-D-glucose. Protein Sci (1995) 0.90

Pyridoxal phosphate site in glycogen phosphorylase b: structure in native enzyme and in three derivatives with modified cofactors. Biochemistry (1987) 0.90

The effect of aspirin on the visual outcome of nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol (1996) 0.90

Solid state 31P cross-polarization/magic angle sample spinning nuclear magnetic resonance of crystalline glycogen phosphorylase b. Biophys J (1993) 0.90

Glucose analogue inhibitors of glycogen phosphorylase: from crystallographic analysis to drug prediction using GRID force-field and GOLPE variable selection. Acta Crystallogr D Biol Crystallogr (1995) 0.89

Effects of novel analogues of D-glucose on glycogen phosphorylase activities in crude extracts of liver and skeletal muscle. Eur J Biochem (1995) 0.89

Crystal structures of hen egg-white lysozyme complexes with gadolinium(III) and gadolinium(III)-N-acetyl-D-glucosamine. Biochem J (1979) 0.89

Flavopiridol inhibits glycogen phosphorylase by binding at the inhibitor site. J Biol Chem (2000) 0.88

Proposals for the catalytic mechanism of glycogen phosphorylase beta prompted by crystallographic studies on glucose 1-phosphate binding. J Mol Biol (1980) 0.88

The binding of 2-deoxy-D-glucose 6-phosphate to glycogen phosphorylase b: kinetic and crystallographic studies. J Mol Biol (1995) 0.88

Comparison of AMP and NADH binding to glycogen phosphorylase b. J Mol Biol (1983) 0.87

Structure of human transthyretin complexed with bromophenols: a new mode of binding. Acta Crystallogr D Biol Crystallogr (2000) 0.87

Mutational analysis supports a structural model for the cell cycle protein kinase p34. Protein Eng (1994) 0.86

Nucleotide binding to glycogen phosphorylase b in the crystal. J Mol Biol (1979) 0.86

The crystal structure of the Escherichia coli maltodextrin phosphorylase-acarbose complex. Biochemistry (1999) 0.86

The structure and function of lysozyme. Sci Prog (1966) 0.86

Towards time-resolved diffraction studies with glycogen phosphorylase. Ciba Found Symp (1991) 0.86

Catalysis in enzyme crystals. Trends Biochem Sci (1988) 0.86

Ocular invasion in mucormycosis. Surv Ophthalmol (1992) 0.86

An interaction between lysozyme and penicillin. Proc R Soc Lond B Biol Sci (1967) 0.86

Crystal structure of the mutant D52S hen egg white lysozyme with an oligosaccharide product. J Mol Biol (1994) 0.85

Surface topography: its influence on wetting and adhesion in a dental adhesive system. J Dent Res (1972) 0.85

Expression of the phosphorylase kinase gamma subunit catalytic domain in Escherichia coli. Protein Eng (1992) 0.84

Time-resolved structural studies on catalysis in the crystal with glycogen phosphorylase b. Biochem Soc Trans (1986) 0.83

Control of phosphorylase b conformation by a modified cofactor: crystallographic studies on R-state glycogen phosphorylase reconstituted with pyridoxal 5'-diphosphate. Protein Sci (1992) 0.83

Electron microscopy of phosphorylase b crystals. J Mol Biol (1972) 0.83

Laue and monochromatic diffraction studies on catalysis in phosphorylase b crystals. Protein Sci (1994) 0.82

Allosteric interactions of glycogen phosphorylase b. A crystallographic study of glucose 6-phosphate and inorganic phosphate binding to di-imidate-cross-linked phosphorylase b. Biochem J (1984) 0.82

The distribution of anionic sites on the surface of the chromaffin granule membrane. J Ultrastruct Res (1976) 0.82

Conformational changes, dynamics and assignments in 1H NMR studies of proteins using ring current calculations. Hen egg white lysozyme. FEBS Lett (1977) 0.81

Magnetic resonance imaging in pituitary apoplexy. Arch Ophthalmol (1988) 0.81

Expression, purification and crystallisation of phosphorylase kinase catalytic domain. J Mol Biol (1995) 0.81

Analysis of the structure of Pseudomonas glumae lipase. Protein Eng (1994) 0.81

Sickle cell trait: an update. J Natl Med Assoc (1982) 0.81

Crystallography. Following proteins in time. Nature (1990) 0.80

Physical and chemical properties of lysozyme. Ciba Found Symp (1977) 0.80

The design of potential antidiabetic drugs: experimental investigation of a number of beta-D-glucose analogue inhibitors of glycogen phosphorylase. Eur J Drug Metab Pharmacokinet (1995) 0.80

A tetragonal crystal form of phosphorylase b. J Mol Biol (1972) 0.79

Oligosaccharide binding to glycogen phosphorylase b. Biochem Soc Trans (1983) 0.79

HLA-A29 as a potential risk factor for nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol (1993) 0.79

Ocular myasthenia gravis. J Natl Med Assoc (1993) 0.78